These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 27149955
1. Altered neuroendocrine control and association to clinical symptoms in adolescent chronic fatigue syndrome: a cross-sectional study. Wyller VB, Vitelli V, Sulheim D, Fagermoen E, Winger A, Godang K, Bollerslev J. J Transl Med; 2016 May 05; 14(1):121. PubMed ID: 27149955 [Abstract] [Full Text] [Related]
5. Clinical symptoms and markers of disease mechanisms in adolescent chronic fatigue following Epstein-Barr virus infection: An exploratory cross-sectional study. Kristiansen MS, Stabursvik J, O'Leary EC, Pedersen M, Asprusten TT, Leegaard T, Osnes LT, Tjade T, Skovlund E, Godang K, Wyller VBB. Brain Behav Immun; 2019 Aug 11; 80():551-563. PubMed ID: 31039432 [Abstract] [Full Text] [Related]
6. Disease mechanisms and clonidine treatment in adolescent chronic fatigue syndrome: a combined cross-sectional and randomized clinical trial. Sulheim D, Fagermoen E, Winger A, Andersen AM, Godang K, Müller F, Rowe PC, Saul JP, Skovlund E, Øie MG, Wyller VB. JAMA Pediatr; 2014 Apr 11; 168(4):351-60. PubMed ID: 24493300 [Abstract] [Full Text] [Related]
7. Cortisol and hypothalamic-pituitary-gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones. Gur A, Cevik R, Nas K, Colpan L, Sarac S. Arthritis Res Ther; 2004 Apr 11; 6(3):R232-8. PubMed ID: 15142269 [Abstract] [Full Text] [Related]
8. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome. Di Giorgio A, Hudson M, Jerjes W, Cleare AJ. Psychosom Med; 2005 Apr 11; 67(3):433-40. PubMed ID: 15911907 [Abstract] [Full Text] [Related]
9. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome. Gaab J, Engert V, Heitz V, Schad T, Schürmeyer TH, Ehlert U. J Psychosom Res; 2004 Apr 11; 56(4):419-24. PubMed ID: 15094026 [Abstract] [Full Text] [Related]
10. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). de Vega WC, Herrera S, Vernon SD, McGowan PO. BMC Med Genomics; 2017 Feb 23; 10(1):11. PubMed ID: 28231836 [Abstract] [Full Text] [Related]
11. Effects of low-dose clonidine on cardiovascular and autonomic variables in adolescents with chronic fatigue: a randomized controlled trial. Fagermoen E, Sulheim D, Winger A, Andersen AM, Gjerstad J, Godang K, Rowe PC, Saul JP, Skovlund E, Wyller VB. BMC Pediatr; 2015 Sep 10; 15():117. PubMed ID: 26357864 [Abstract] [Full Text] [Related]
12. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome. Gaab J, Rohleder N, Heitz V, Engert V, Schad T, Schürmeyer TH, Ehlert U. Psychoneuroendocrinology; 2005 Feb 10; 30(2):188-98. PubMed ID: 15471616 [Abstract] [Full Text] [Related]
13. Are there subgroups of chronic fatigue syndrome? An exploratory cluster analysis of biological markers. Asprusten TT, Sletner L, Wyller VBB. J Transl Med; 2021 Jan 30; 19(1):48. PubMed ID: 33516248 [Abstract] [Full Text] [Related]
14. Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. Neeck G, Crofford LJ. Rheum Dis Clin North Am; 2000 Nov 30; 26(4):989-1002. PubMed ID: 11084955 [Abstract] [Full Text] [Related]
15. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome. Van Den Eede F, Moorkens G, Hulstijn W, Van Houdenhove B, Cosyns P, Sabbe BG, Claes SJ. Psychol Med; 2008 Jul 30; 38(7):963-73. PubMed ID: 17803834 [Abstract] [Full Text] [Related]
16. Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome. Morris MC, Cooney KE, Sedghamiz H, Abreu M, Collado F, Balbin EG, Craddock TJA, Klimas NG, Broderick G, Fletcher MA. Clin Ther; 2019 Apr 30; 41(4):656-674.e4. PubMed ID: 30929860 [Abstract] [Full Text] [Related]
17. Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction. Heim C, Nater UM, Maloney E, Boneva R, Jones JF, Reeves WC. Arch Gen Psychiatry; 2009 Jan 30; 66(1):72-80. PubMed ID: 19124690 [Abstract] [Full Text] [Related]
18. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment. Inder WJ, Prickett TC, Mulder RT. Clin Endocrinol (Oxf); 2005 Mar 30; 62(3):343-8. PubMed ID: 15730417 [Abstract] [Full Text] [Related]
19. Research progress in the treatment of chronic fatigue syndrome through interventions targeting the hypothalamus-pituitary-adrenal axis. Zhang YD, Wang LN. Front Endocrinol (Lausanne); 2024 Mar 30; 15():1373748. PubMed ID: 38660512 [Abstract] [Full Text] [Related]